San Mateo, CA, United States of America

Xi Alan Huang



Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Xi Alan Huang in Treating Inflammatory Diseases

Introduction

Xi Alan Huang is an accomplished inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for inflammatory and immune-related diseases. With a portfolio that includes two patents, Huang is recognized for his innovative approaches to addressing atopic diseases and cancer.

Latest Patents

Huang's latest inventions focus on asthma and allergic inflammation modulators. His patents include compounds, pharmaceutical compositions, and methods designed to treat inflammatory conditions and immune-related diseases. These groundbreaking compounds specifically modulate the function and/or expression of proteins that are critical in managing atopic diseases, inflammatory conditions, and cancer. The subject compounds are categorized as carboxylic acid derivatives, showcasing Huang's expertise in pharmaceutical chemistry.

Career Highlights

Currently, Xi Alan Huang works at Amgen Inc., a leading biotechnology company where he applies his extensive knowledge and skills in drug development. His work significantly contributes to Amgen’s mission of advancing global health through innovative therapeutics that improve patient outcomes.

Collaborations

In his career, Huang has collaborated with talented professionals such as Zice Fu and Jiwen Liu. Together, they have worked on projects that are pivotal in enhancing the understanding and treatment of various inflammatory diseases. Their collaboration exemplifies the importance of teamwork in the research and development of new medical solutions.

Conclusion

In conclusion, Xi Alan Huang stands out as a notable inventor whose work in developing asthma and allergy modulators demonstrates his commitment to improving healthcare outcomes. With his strategic collaborations at Amgen Inc., Huang continues to push the boundaries of innovation in the pharmaceutical industry, aiming to provide effective solutions for complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…